PharmaNordic ApS: Financial statements 2019
CVR: 36408464
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PharmaNordic ApS (CVR 36408464) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 289,021 and a net result of DKK -87,787 compared with DKK 109,472 the year before. That is a decrease of 39.3% compared with the year before. Equity in the 2019 report amounted to DKK -228,864.
- Gross Profit
- DKK 289,021
- Profit/Loss
- DKK -87,787
- Equity
- DKK -228,864
- Total Assets
- DKK 175,996
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 289 t. | -88 t. | -229 t. | - |
| 2018 | - | 476 t. | 109 t. | -141 t. | - |
| 2017 | - | 242 t. | -51 t. | -251 t. | - |
| 2016 | - | 190 t. | -65 t. | -199 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of July 24, 2019, LENTINI HOLDING ApS is registered as an owner of PharmaNordic ApS with an ownership share of 100%.
PharmaNordic ApS has published its annual report for 2018. Gross profit came to DKK 476,274, and the net result was DKK 109,472.
About PharmaNordic ApS
PharmaNordic ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2014. The company is registered under the industry Planlægning og design af reklamekampagner. The management consists of Anders Lentini From. The company is owned by LENTINI HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -197,662 and a net result of DKK 2,313,695 compared with DKK 647,775 the year before. Equity in the 2025 report amounted to DKK 4,025,013.